Original Research
Published on 27 Aug 2024
Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis
in Cancer Immunity and Immunotherapy
![Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis](https://www.frontiersin.org/files/myhome article library/1399613/1399613_Thumb_400.jpg)